Why the Little Green Pharma (ASX:LGP) share price climbed 5% today

The Little Green Pharma (ASX: LGP) share price climbed higher today after the company announced it has delivered its first French shipment.

| More on:
asx cannabis shares represented by pug dog pointing to blackboard with cannabis info on it

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Little Green Pharma Ltd (ASX: LGP) share price climbed higher today after the company announced it has delivered its first French shipment. By the close of trade, the medicinal cannabis company's shares had moved up by 5.47% to an intraday high 67.5 cents.

What did Little Green Pharma announce?

The Little Green Pharma share price trekked upwards after the company provided investors with the positive news.

According to its release, Little Green Pharma has completed the first shipment of its medicinal cannabis oils to the French national trial.

Authorities will test the first batch of the 4,800 units which will be made available to trial patients sometime this month. The company hopes that having a first-mover advantage in the country could set it up for potential blockbuster growth.

Little Green Pharma is only one of four international cannabis companies that were appointed as primary trial suppliers. The company partnered up with leading French pharmaceutical distributor, Intsel Chimos, to assist in delivering the medicinal cannabis oils.

The French national study is seeking to look at efficacy and safety for patients being treated with medicinal cannabis products. The program is expected to comprise up to 3,000 people and will run for a period of two years.

At the moment, the study represents the only pathway for medicinal cannabis to be supplied to the French market. The trial complements Little Green Pharma's European strategy which has already seen it enter the United Kingdom and Germany.

Little Green Pharma estimates that the legalised medicinal cannabis sector in France could potentially be worth 4 billion euros (AUD$6.3 billion) annually.

How has the company been performing?

In the six months ending 31 December 2020, Little Green Pharma achieved strong growth with significant unit sales and revenue.

In Australia, the company sold over 21,000 units which represented an increase of 340% on the prior corresponding period. It also exported its first commercial shipment of 2,400 units to Germany 

Total revenue for the first half came to $3.7 million, accelerating 420% from the same time last year.

As a result, Little Green Pharma's bottom line saw net profit after tax (NPAT) just shy of $0.5 million. This is a massive turnaround for the company which posted a loss of $5.5 million in the prior period.

At the end of the calendar year, the company recorded $4.4 million in cash and equivalents.

Little Green Pharma share price review

Over the past 12 months, the Little Green Pharma share price has gone gangbusters, rising by 125%. Year to date, the company's shares have gained just over 20%.

Based on the current share price, Little Green Pharma has a market capitalisation of around $81 million.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Animation of a man measuring a percentage sign, symbolising rising interest rates.
Share Market News

Here's when Westpac says the RBA will now cut interest rates

Will borrowers need to wait until the middle of next year for relief? Let's find out.

Read more »

Boys making faces and flexing.
Opinions

3 ASX 300 shares to buy and hold for the long run

I believe these stocks have loads of growth potential.

Read more »

Young girl drinking milk showing off muscles.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the trading week for ASX investors today.

Read more »

Hands reaching high for a trophy with a sunset in the background.
Record Highs

The ASX 200 Index is on its way to another all-time high today. Here's why

These blue chip stocks are driving the index towards a new record today...

Read more »

Group of friends trading stocks on their phones. symbolising the 3 most traded ASX 200 shares today
Share Market News

3 ASX mining stocks topping the most-traded list in October

Chinese stimulus news and company announcements likely contributed to the higher trading activity.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Share Gainers

3 ASX 200 stocks smashing the benchmark this week

These three ASX 200 stocks are leading the charge this week. Here’s how.

Read more »

Two people tired and resting after sports race.
Broker Notes

Fundie rates 2 ASX 200 stocks in short-term pain but with long-term gain potential

Blackwattle Investment Partners sees these 2 ASX 200 stocks as worthy of a buy and hold strategy.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why A2 Milk, EOS, GQG, and Mineral Resources shares are racing higher today

These shares are ending the week strongly. But why?

Read more »